Search
Innate Pharma SA
IPHAAdd to Watchlist
1.800USD
-0.010-0.55%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
171.76MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
4
analysts
Buy
Current Rating
6.348
Target Price
+252.67%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
562
Total
5
Median
6
Average
Company name
Ratings
Analysts
Innate Pharma SA
IPHA
4
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
CRISPR Therapeutics AG
CRSP
26
1
2
3
...
113
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
FAQs
What is Innate Pharma SA's price target?
Analysts forecast that Innate Pharma SA's price target is USD 6.00, with the highest forecast at USD 11.00 and the lowest forecast at USD 2.00.
What is the analyst rating for Innate Pharma SA?
Based on the ratings of Innate Pharma SA's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.